Intervention

Rilonacept

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting1

Common conditions3

Lead sponsors shown3

Clinical trials

3 shown

Rilonacept in Subjects With Cardiac SarcoidosisNCT06660732 · 2025-03-05

RECRUITING

Rilonacept in Diabetes Mellitus Type 1: Safety StudyNCT00962026 · 2011-02-01

COMPLETED

Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young AdultsNCT00534495 · 2008-11-01

COMPLETED

Common conditions

Cardiac Sarcoidosis1 Juvenile Idiopathic Arthritis1 Type 1 Diabetes Mellitus1

Leading sponsors

Mayo Clinic 1 Montefiore Medical Center 1 University of Texas Southwestern Medical Center 1

Trial status mix

COMPLETED2

RECRUITING1

Phase mix

PHASE22

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.